Johnson & Johnson Q3 net earnings fall 96% to $210 million; sales rise 6% to $25.4 billion
Johnson & Johnson posted Q3 2026 net earnings of USD 210 million, swinging from profit a year earlier. Reported sales rose 6% to USD 25.4 billion versus Q3 2025. * Innovative Medicine net sales climbed 8% to USD 16.76 billion, while MedTech net sales increased to USD 8.64 billion. CEO Joaquín Duato cited “accelerating